$1.08
-0.03-2.7%
TELA Bio (TELA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TELA Bio (TELA) ha pubblicato l'ultima guidance il maggio 12, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a per il periodo.
Rispetto alle previsioni precedenti, TELA Bio {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
TELA Bio ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il TELA Bio. 16
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.18 | $-0.18 | $-0.18 | $-0.19 |
| Actual | $-0.20 | $-0.21 | $-0.17 | $-0.19 |
| Surprise | -11.1% | -16.7% | +5.56% | 0.00% |
| Revenue | ||||
| Estimate | $20.0M | $18.9M | $21.0M | $21.8M |
| Actual | $19.3M | $19.1M | $20.9M | $20.7M |
| Surprise | -3.58% | +0.84% | -0.74% | -5.17% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.16 | $-0.13 | $-0.10 | $-0.11 |
| Revenue | ||||
| Consensus | $19.8M | $21.0M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.20 | $-0.18 | -11.1 % |
| Q1 | May 12, 2026 | $-0.21 | $-0.18 | -16.7 % |
| Q4 | Mar 24, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q3 | Nov 13, 2025 | $-0.19 | $-0.19 | 0.00 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $19.29M | $20.01M | -3.58 % |
| Q1 | May 12, 2026 | $19.06M | $18.90M | 0.84 % |
| Q4 | Mar 24, 2026 | $20.87M | $21.02M | -0.74 % |
| Q3 | Nov 13, 2025 | $20.70M | $21.83M | -5.17 % |